𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlation between angiographically assessed vascularity and blood flow in hepatic metastases in patients with colorectal carcinoma

✍ Scribed by Akihiro Yamaguchi; Hiroki Taniguchi; Satoshi Kunishima; Toshimori Koh; Hisakazu Yamagishi

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
358 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Resection of hepatic and pulmonary metas
Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma
✍ Satoshi Ambiru; Masaru Miyazaki; Hiroshi Ito; Koji Nakagawa; Hiroaki Shimizu; At πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

Hideyuki Omoto, M.D. ## RESULTS. Five of the patients included four who underwent pulmonary resection Nobuyuki Nakajima, M.D. for pulmonary metastases after initial hepatic resection for hepatic metastases and one patient who underwent hepatic metastasis resection after initial pulmonary The Fir

Resection of hepatic and pulmonary metas
Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma
✍ Lorenzo Spaggiari; Dominique Grunenwald; Jean FranΓ§ois Regnard πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

## Resection of Hepatic and Pulmonary Metastases in Patients with Colorectal Carcinoma W e read with interest the article by Ambiru et al. 1 concerning the resection of colorectal hepatic and pulmonary metastases. In a population of 156 patients with resected hepatic metastases from colorectal car

Resection of both hepatic and pulmonary
Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma
✍ Satoshi Murata; Yoshihiro Moriya; Takayuki Akasu; Shin Fujita; Kenichi Sugihara πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

## BACKGROUND. More than 40% of patients who undergo curative resection of advanced colorectal carcinoma can be expected to have recurrence of the disease. The most frequent sites of recurrence are the liver (33% of patients) and lung (22%). Interest has therefore focused on treating hepatic or